{"entity":{"id":"krankenhaus-nordwest","kind":"institution","name":"Krankenhaus Nordwest / Institute of Clinical Cancer Research (IKF)","aka":["Institut für Klinisch-Onkologische Forschung","IKF Frankfurt","UCT Frankfurt partner hospital"],"tldr":"Frankfurt teaching hospital whose Institute of Clinical Cancer Research ran FLOT4, the trial that made FLOT chemotherapy the standard before and after surgery for stomach cancer.","summary":"Krankenhaus Nordwest is a teaching hospital of Goethe University in the north-west of Frankfurt. Its Institute of Clinical Cancer Research (IKF), directed by Salah-Eddin Al-Batran, is a trial office for the German AIO cooperative group in gastrointestinal cancer and coordinated the FLOT4 trial, whose 2019 Lancet report established perioperative FLOT for resectable gastric and gastro-oesophageal junction adenocarcinoma. The hospital is a partner site of the University Cancer Center Frankfurt.","asOf":"2026-09-18","links":[{"label":"Krankenhaus Nordwest","url":"https://www.krankenhaus-nordwest.de"}],"tags":[],"related":[],"cancers":["gastric","esophageal"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["uct-frankfurt"],"pathways":[],"terms":[],"trials":["flot4"],"people":["salah-eddin-al-batran"],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Frankfurt am Main","country":"DE","lat":50.13,"lng":8.633,"institutionType":"hospital","website":"https://www.krankenhaus-nordwest.de","programs":["Gastro-oesophageal cancer trials (AIO)","Perioperative chemotherapy"]},"route":"/institutions/krankenhaus-nordwest/","neighbours":{"cancer":[{"id":"gastric","kind":"cancer","name":"Gastric & gastro-oesophageal junction cancer","route":"/cancers/gastric/"},{"id":"esophageal","kind":"cancer","name":"Oesophageal cancer","route":"/cancers/esophageal/"}],"institution":[{"id":"uct-frankfurt","kind":"institution","name":"University Cancer Center Frankfurt (UCT)","route":"/institutions/uct-frankfurt/"}],"trial":[{"id":"flot4","kind":"trial","name":"FLOT4-AIO","route":"/trials/flot4/"},{"id":"gain-igbc","kind":"trial","name":"GAIN (AIO/CALGP/ACO)","route":"/trials/gain-igbc/"}],"person":[{"id":"salah-eddin-al-batran","kind":"person","name":"Salah-Eddin Al-Batran","route":"/people/salah-eddin-al-batran/"}],"paper":[{"id":"paper-gain-trial-protocol-bmc-cancer-2020","kind":"paper","name":"Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) - a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)- the AIO/ CALGP/ ACO- GAIN-trial","route":"/key-papers/paper-gain-trial-protocol-bmc-cancer-2020/"}],"idea":[{"id":"idea-gbc-neoadjuvant-for-high-risk-incidental-cancer","kind":"idea","name":"Chemotherapy before the second operation for high-risk incidental gallbladder cancer","route":"/ideas/idea-gbc-neoadjuvant-for-high-risk-incidental-cancer/"}]}}